Klaus Überla to Humans
This is a "connection" page, showing publications Klaus Überla has written about Humans.
Connection Strength
0.049
-
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020. Viruses. 2021 06 10; 13(6).
Score: 0.008
-
Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines. J Virol. 2018 07 15; 92(14).
Score: 0.006
-
Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines. Curr Opin HIV AIDS. 2017 May; 12(3):272-277.
Score: 0.006
-
Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus. PLoS One. 2012; 7(5):e38068.
Score: 0.002
-
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity. Eur J Immunol. 2021 10; 51(10):2478-2484.
Score: 0.002
-
Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2. Lancet Infect Dis. 2021 09; 21(9):1212-1213.
Score: 0.002
-
SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses. Front Immunol. 2021; 12:627568.
Score: 0.002
-
Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19. Gut. 2021 09; 70(9):1605-1608.
Score: 0.002
-
Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection. Eur J Immunol. 2021 06; 51(6):1436-1448.
Score: 0.002
-
Complement Activation in Kidneys of Patients With COVID-19. Front Immunol. 2020; 11:594849.
Score: 0.002
-
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro. Viruses. 2020 12 05; 12(12).
Score: 0.002
-
Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients. Transfusion. 2021 02; 61(2):368-374.
Score: 0.002
-
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2021 Apr; 40(4):751-759.
Score: 0.002
-
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020 07 24; 11(1):3774.
Score: 0.002
-
Burden of disease due to human coronavirus NL63 infections and periodicity of infection. J Clin Virol. 2010 Jun; 48(2):104-8.
Score: 0.002
-
Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8+ T cells. Immun Inflamm Dis. 2018 03; 6(1):163-175.
Score: 0.001
-
A clinician's plea to test glioma patients for CMV. Neuro Oncol. 2017 09 01; 19(9):1282-1283.
Score: 0.001
-
Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies. Virology. 2007 May 25; 362(1):26-37.
Score: 0.001
-
Croup is associated with the novel coronavirus NL63. PLoS Med. 2005 Aug; 2(8):e240.
Score: 0.001
-
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol. 2004 Jun; 78(12):6134-42.
Score: 0.001